UNSPSC 85815215: Introduction of monoclonal antibody into respiratory tract, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into respiratory tract, via natural or artificial opening endoscopic. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0F80M

UNSPSC 85815215 "Introduction of monoclonal antibody into respiratory tract, via natural or artificial opening endoscopic" is a Commodity code that shows little relevant recent activity. The recent state and local opportunities tagged with this code do not involve monoclonal antibody infusions or respiratory-tract interventions; instead, they span virtual urgent care, medical services, PACE operations, cancer registry services, occupational health, EMT staffing, employee health clinics, behavioral health programs, recovery services, and medical staffing — none of which map to the code's clinical scope. The code appears to have been applied inconsistently or as a catchall tag for health services procurement more broadly.

The issuing bodies across the recent opportunities include state health authorities and departments (Nevada Health Authority, Texas Health and Human Services Commission, Colorado Department of Human Services, New Jersey Department of Health), county and municipal health systems and departments (San Mateo County, Seminole County, Santa Clara County, Solano County, Jackson County, Ventura County, Fairfax County), school districts (Parkway School District), and specialty districts and authorities (Inland Empire Health Plan, Events DC). Geographic spread spans California, Georgia, Nevada, Florida, Illinois, Colorado, New York, Texas, Washington, Kansas, Missouri, Oregon, and the District of Columbia. Geographic concentration is light; no state dominates recent posting activity. Given the mismatch between the code's nominal scope and the work actually being solicited, the code does not present a coherent procurement signal for business development targeting monoclonal antibody respiratory delivery services.